AMP-001-003 enhanced doxorubicin induced apoptosis in several cancer cells including TNBC cells via ROS-dependent mitochondrial apoptotic pathway, activation of cell death pathway (CD95) and inhibition of survival pathways (NF-kB and PARP). This evidence concerns the gene NFKB1 and cancer.